C. Michael Gibson MD Evandro Martins F. MD The most relevant message from the trial, yes, Sanjit Jolly is very smart!

Ultrasound Guidance for Vascular Access for Cardiac Procedures: A Randomized Trial (UNIVERSAL) - tctmd.com ⁦C. Michael Gibson MD⁩ ⁦PHRI.ca Population Health Research Institute 🇨🇦⁩ ⁦TCT Conference⁩ tctmd.com/videos/ultraso…

Pleasure chatting with Matt Cavender and SunMoonKim, Universal trial ACCEL podcast TCT Conference American College of Cardiology PHRI.ca Population Health Research Institute 🇨🇦 McMaster University Department of Medicine

Calling all New England IC Fellows: Don’t miss the SCAI First fellows-focused event on Thursday, January 26, discussing complications and how to manage or avoid potential disasters. ➡️ Register Now: scaipro.scai.org/URL/SFNE-Jan20… ➡️ Submit Your Case: scaipro.scai.org/URL/SFCaseSubm…

#CRT2023 simultaneous publication. In the randomized UNIVERSAL trial, ultrasound-guided femoral access was associated with fewer major bleeding and vascular complications compared to a non-guided strategy especially when a vascular closure device was used. eurointervention.pcronline.com/article/ultras…

CRT2023, Chet Rihal Chet Rihal Ron Waksman ron waksman Highest attendance ever!

Women as one with ⁦Dr Roxana Mehran⁩ ⁦Julie Tyler⁩ ⁦OPCI⁩. Amazing story Roxana!

Novasight hybrid IVUS/OCT, great innovation ⁦OPCI⁩

No-reflow management in STEMI patients undergoing PCI is poorly defined. This core laboratory analysis of the TOTAL trial (n=1,800) shows that while thrombectomy did not reduce no-reflow in all patients, it may have a synergism with direct stenting. eurointervention.pcronline.com/article/no-ref…

The ROTA-CUT trial evaluates the impact of combining rotational atherectomy with cutting balloon angioplasty compared to non-compliant balloon angioplasty for calcified lesions in the context of PCI. No significant difference was found in minimum stent area or procedural safety

Enrolled first patient in Canada to STEMI DTU trial! Looking forward to seeing results of trial. Navin Kapur @Abiomed Gregg W. Stone MD William W. O'Neill

In the first US trial evaluating a drug-coated balloon for coronary in-stent restenosis, we found that the Agent paclitaxel balloon reduced target lesion failure by > 40% compared with conventional angioplasty. Now FDA approved. Published in JAMA now: jamanetwork.com/journals/jama/…

Original Article: Colchicine in Acute Myocardial Infarction (CLEAR) nej.md/4i2U6dV #Cardiology

A big thank you to all the CLEAR SYNERGY investigators worldwide NEJM PHRI.ca Population Health Research Institute 🇨🇦 McMaster University AHA Science

Presented at TCT and now available PHRI.ca Population Health Research Institute 🇨🇦 McMaster University TCT Conference TCTMD

doi.org/10.1016/j.jsca…

ICYMI: Top 🔟 Clinical Trials of 2024: 🔥 PREVENT 🔥 DanGer Shock 🔥 REDUCE-AMI 🔥 CLEAR SYNERGY (OASIS 9) 🔥 And more! Read the details of the clinical trials here: bit.ly/41Kb7nn

See this chart, it will help Canadians support ourselves as the orange goblin’s tariffs take effect. Pass it on Canada 🇨🇦 #BuyCanadian

📢 The conference is coming up! The program features both #CTO and non-CTO #ComplexPCI content. 🎟️We’ve secured discounts on flights and accommodations for conference delegates - and trainees benefit from complimentary registration! 🔗 Register now at cancto.ca